NRC — NRC Health Share Price
Last trade - 00:00- $466.94m
- $553.65m
- $137.39m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 20.78 | ||
| PEG Ratio (f) | 0.78 | ||
| EPS Growth (f) | 36.11% | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 71.3 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | 21.58 | ||
| Price to Sales | 3.34 | ||
| EV to EBITDA | 23.69 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 14.57% | ||
| Return on Equity | 39.82% | ||
| Operating Margin | 10.53% | ||
Financial Summary
| Year End 31st Dec | Unit | 2021 | 2022 | 2023 | 2024 | 2025 | 2026E | 2027E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 147.95 | 151.57 | 148.58 | 143.06 | 137.39 | 142.6 | 154.5 | 0.61% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +2.35 | +14.93 | -25.39 | -16.47 | -51.93 | +60.59 | +32.1 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
NRC Health, formerly National Research Corporation, provides healthcare experience improvement solutions. The Company is focused on improving the challenged healthcare ecosystem with stakeholder experience insights, market intelligence data, and software tools that enable health systems to improve patient outcomes and hospital operations. Its solutions consist of four solution categories: Patient Experience, Consumer Experience, Employee Experience, and Market Experience. The Company's portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.
Directors
- Michael Hays PRE (66)
- Kevin Karas CFO (63)
- Jona Raasch COO (62)
- Helen Hrdy OTH (56)
- John Nunnelly LED (68)
- Donald Berwick IND (74)
- Stephen Lockhart IND (62)
- JoAnn Martin IND (66)
- Penny Wheeler IND (63)
- Last Annual
- December 31st, 2025
- Last Interim
- June 30th, 2026
- Incorporated
- June 30th, 2021
- Public Since
- October 1st, 1997
- No. of Shareholders
- 12,697
- No. of Employees
- 357
- Sector
- Media & Publishing
- Industry
- Consumer Cyclicals
- Exchange
- NASDAQ Global Select Market
- Shares in Issue
- 22,119,566
- Address
- 1245 Q Street, LINCOLN, 68508
- Web
- https://nrchealth.com/
- Phone
- +1 3026587581
- Auditors
- KPMG LLP
Latest News for NRC
Upcoming Events for NRC
Q3 2026 NRC Health Earnings Release
Q3 2026 NRC Health Earnings Call
Q4 2026 NRC Health Earnings Release
Similar to NRC
Advantage Solutions
NASDAQ Global Select Market
AMC Global Media
NASDAQ Global Select Market
comScore
NASDAQ Global Select Market
Criteo SA (Pre-Reincorporation)
NASDAQ Global Select Market
E W Scripps
NASDAQ Global Select Market
FAQ
As of Today at 04:26 UTC, shares in NRC Health are trading at $21.11. This share price information is delayed by 15 minutes.
Shares in NRC Health last closed at $21.11 and the price had moved by +84.37% over the past 365 days. In terms of relative price strength the NRC Health share price has outperformed the S&P500 Index by +57.82% over the past year.
The overall consensus recommendation for NRC Health is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreThe NRC Health dividend yield is 2.84% based on the trailing twelve month period.
Last year, NRC Health paid a total dividend of $0.60, and it currently has a trailing dividend yield of 2.84%. We do not have any data on when NRC Health is to next pay dividends.
We do not have data on when NRC Health is to next pay dividends. The historic dividend yield on NRC Health shares is currently 2.84%.
To buy shares in NRC Health you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $21.11, shares in NRC Health had a market capitalisation of $466.94m.
Here are the trading details for NRC Health:
- Country of listing: United States
- Exchange: NSQ
- Ticker Symbol: NRC
Based on an overall assessment of its quality, value and momentum NRC Health is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in NRC Health is $26.00. That is 23.16% above the last closing price of $21.11.
Analysts covering NRC Health currently have a consensus Earnings Per Share (EPS) forecast of $0.81 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like NRC Health. Over the past six months, its share price has outperformed the S&P500 Index by +7.48%.
As of the last closing price of $21.11, shares in NRC Health were trading +10.86% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The NRC Health PE ratio based on its reported earnings over the past 12 months is 20.78. The shares last closed at $21.11.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
NRC Health's management team is headed by:
- Michael Hays - PRE
- Kevin Karas - CFO
- Jona Raasch - COO
- Helen Hrdy - OTH
- John Nunnelly - LED
- Donald Berwick - IND
- Stephen Lockhart - IND
- JoAnn Martin - IND
- Penny Wheeler - IND